Carcinoma of the Esophagus Part 1: Primary Therapy

ONCOLOGY

Volumn 13, Issue 9, 1999, Pages 1225-1236

  Minsky, Bruce D ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN SULFATE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRIDIUM 192; MITOMYCIN; MITOMYCIN C; VINDESINE;

ADENOCARCINOMA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSPHAGIA; ESOPHAGUS CARCINOMA; ESOPHAGUS STRICTURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; PROGNOSIS; RADIOTHERAPY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0033502658     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Phillips TL, Minsky BD, Dicker A, et al: Cancer of the esophagus, in Leibel SA and Phillips TA (eds): Textbook of Radiation Oncology, pp601-623. Philadelphia, WB Saunders, 1998.
2. De-Ren S: Ten-year follow-up of esophageal cancer treated by radical radiation therapy: Analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329-334, 1989.
3. Newaishy GA, Read GA, Duncan W, et al: Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 33:347-352, 1982.
4. Okawa T, Kita M, Tanaka M, et al: Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 17:49-54, 1989.
5. Herskovic A, Martz LK, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992.
6. Al-Sarraf M, Martz K, Herskovic A, et al: Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients with esophageal cancer: Final report of an intergroup randomized and confirmed study (abstract). Proc Am Soc Clin Oncol 15:206, 1996.
7. Sykes AJ, Burt PA, Slevin NJ, et al: Radical radiotherapy for carcinoma of the oesophagus: An effective alternative to surgery. Radiother Oncol 48:15-21, 1998.
8. John MJ, Flam M, Ager Mowry PA, et al: Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. Cancer 63:2397-2403, 1989.
9. Coia LR, Engstrom PF, Paul AR, et al: Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal cancer. Int J Radiat Oncol Biol Phys 20:29-36, 1991.
10. Izquierdo MA, Marcuello E, Gomez de Segura G, et al: Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy. Cancer 71:287-292, 1993.
11. Seitz JF, Giovannini M, Padaut-Cesana J, et al: Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 66:214-219, 1990.
12. Valerdi JJ, Tejedor M, Illarramendi JJ, et al: Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: Long-term results. Int J Radiat Oncol Biol Phys 27:843-847, 1994.
13. Poplin EA, Jacobson J. Herskovic A, et al: Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060. Cancer 78:1851-1866, 1996.
14. Araujo CMM, Souhami L, Gil RA, et al: A randomized trial comparing radialion therapy vs concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67:2258-2261, 1991.
15. Roussel A, Jacob JH, Jung GM, et al: Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: A study of the EORTC gastrointestinal tract cancer cooperative group, in Schlag P, Hohenberger P, Metzger U (eds): Recent Results in Cancer Research, 1st ed, pp 21-30. Berlin, Springer-Verlag, 1988.
16. Nygaard K, Hagen S, Hansen HS, et al: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy: The second Scandinavian trial in esophageal cancer. World J Surg 16:1104-1110, 1992.
17. Al-Sarraf M, Martz K, Herskovic A, et al: Progress report of combined chemoradiotherapy vs radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 15:277-284, 1997.
18. Slabber CF, Nel JS, Schoeman L, et al: A randomized study of radiotherapy alone vs radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cell cancer of the esophagus. Am J Clin Oncol (CCT) 21:462-465, 1998.
19. Smith TJ, Ryan LM, Douglass HO, et al: Combined chemoradiotherapy vs radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269-276, 1998.
20. Minsky BD, Neuberg D, Kelsen DP, et al: Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517-523, 1999.
21. Kelsen DP, Minsky BD, Smith M, et al: Preoperative therapy for esophageal cancer: A randomized comparison of chemotherapy vs radiation therapy. J Clin Oncol 8:1352-1361, 1990.
22. Roca E, Pennella E, Sardi M, et al: Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer. Eur J Cancer 32A:429-432, 1996.
23. Kelsen D, Ilson D, Lipton R, et al: A phase I trial of radiation therapy (RT) plus concurrent fixed dose cisplatin (C) with escalating doses of paclitaxel (P) as a 96-hour continuous infusion in patients (PTS) with localized esophageal cancer (EC) (abstract). Proc Am Soc Clin Oncol 18:271, 1999.
24. Armstrong JG. High-dose rate remote afterloading brachytherapy for lung and esophageal cancer. Semin Radiat Oncol 4:270-277, 1993.
25. Jager J, Langendijk H, Pannebakker M, et al: A single session of intraluminal brachytherapy in palliation of esophageal cancer. Radiother Oncol 37:237-240, 1995.
26. Moni J, Armstrong JG, Minsky BD, et al: High-dose rate intraluminal brachytherapy for carcinoma of the esophagus. Dis Esophagus 9:123-127, 1996.
27. Calais G, Dorval E, Louisot P, et al: Radiotherapy with high-dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 38:769-775, 1997.
28. Caspers RJL, Zwinderman AH, Griffioen G, et al: Combined external beam and low-dose rate intraluminal radiotherapy in oesophageal cancer. Radiother Oncol 27:7-12, 1993.
29. Sur RK, Singh DP, Sharma SC: Radiation therapy of esophageal cancer: role of high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 22:1043-1046, 1992.
30. Gaspar LE, Qian C, Kocha WI, et al: A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int J Radiat Oncol Biol Phys 37:593-599, 1997.
31. Gaspar LE, Nag S, Herskovic A, et al: American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 38:127-132, 1997.
32. Calais G, Jadaud E, Chapet S, et al: High dose radiotherapy (RT) and concomitant chemotherapy for nonesectable esophageal cancer: Results of a phase II study (abstract). Proc Am Soc Clin Oncol 13:197, 1994.
33. Girinsky T, Auperin A, Marsiglia H, et al: Accelerated fractionation in esophageal cancers: A multivariate analysis on 88 patients. Int J Radiat Oncol Biol Phys 38:1013-1018, 1997.
34. Powell MEB, Hoskin PJ, Saunders MT, et al: Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys 38:133-136, 1997.
35. Jeremic B, Shibamoto Y, Acimovic L, et al: Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: A phase II study. Int J Radiat Oncol Biol Phys 40:1061-1066, 1998.
36. Wara WM, Mauch PM, Thomas AN, et al: Palliation for carcinoma of the esophagus. Radiology 121:717-720, 1976.
37. Petrovich Z, Langholz B, Formenti S, et al: Management of carcinoma of the esophagus: The role of radiotherapy. Am J Clin Oncol (CCT) 14:80-86, 1991
38. Whittington R, Coia LR, Haller DG, et al: Adenocarcinoma of the esophagus and esophagogastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys 19:593-603, 1990.
39. Caspers RJL, Welvaart K, Verkes RJ, et al: The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol 12:15-23, 1988
40. Algan O, Coia LR, Keller SM, et al: Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: Results of sequential nonrandomized phase II studies. Int J Radiat Oncol Biol Phys 32:753-761, 1995.
41. Gill PG, Denham JW, Jamieson GG, et al: Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment of followed by surgery. J Clin Oncol 10:1037-1043, 1992.
42. Urba SG, Turrisi AT: Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 75:435-439, 1995.
43. Coia LR, Soffen EM, Schultheiss TE, et al: Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 71:281-286, 1993.
44. O'Rourke IC, Tiver K, Bull C, et al: Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer 61:2022-2026, 1988.
45. Minsky BD: Radiation therapy in the treatment of esophagus cancer. Chest Surg Clin North Am 4:285-297, 1994.
46. Kok TC, Lanschot JV, Siersema PD, et al: Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized trial (abstract). Proc Am Soc Clin Oncol 16:277, 1997.
47. Kelsen DP, Ginsberg R, Pajak T, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998.
48. Bhansali MS, Fujita H, Kakegawa T, et al: Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21:275-281, 1997.
49. Nishimaki T, Suzuki T, Suzuki S, et al: Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186:306-312, 1998.